Intriguingly, administration of 1,200 μg mAb for 17 days effectively suppressed tumor growth in an orthotopic MASLD-HCC mouse model, which was accompanied by suppression of the AKT/β-catenin signaling pathway. This evidence concerns the gene AKT1 and hepatocellular carcinoma.